Andrew Simpson serves as Executive at Heart Test Laboratories, Inc., where they oversee executive responsibilities. Since joining the company, Andrew Simpson has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 28, 2025 involved receiving (via award) 70,000 shares valued at $0.
Andrew Simpson currently holds 74,382 shares of Heart Test Laboratories, Inc. (HSCS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Simpson has been a net neutral trader of HSCS stock. They have purchased $0 and sold $0 worth of shares.
Andrew Simpson's most recent insider trade was on Nov 28, 2025, when they sold 70,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |